Delivery Order SPE2D021D0003-SPE2D325F199F
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,832 firm fixed-price delivery order to Sagent Pharmaceuticals, Inc. for the supply of Cefepime HCL 2 gram vials. The contract, which was awarded on July 8, 2025, with an ultimate completion date of July 11, 2025, involves no set-aside designation, indicating the vendor competed on merit. Performance will take place at Sagent's facility in Schaumburg, Illinois. This delivery order falls under Sagent's existing single-award...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer, for the supply of 4,558 units of Cefepime 2 gram solution for injections. The $145,984 delivery order was placed against an existing indefinite delivery/indefinite quantity contract with Sagent to provide injectable pharmaceutical products to support military healthcare programs. The award was not set aside for any special...
- This federal contract award to Sagent Pharmaceuticals, Inc. is for the delivery of 4,565,768,859 units of Cefepime 2 gram solution for injections. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on September 11, 2024 with a ceiling value of $10,112.00. This is a firm fixed-price delivery order contract with a period of performance through September 16, 2024. Sagent Pharmaceuticals, a for-profit pharmaceutical manufacturer, will supply...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer, for the supply of cefepime 2 gram solution for injection. The order was placed under Sagent's $29.6 million single-award indefinite delivery/indefinite quantity (ID/IQ) contract with DLA for pharmaceutical products and medical supplies to support Department of Defense healthcare needs. The contract does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer based in Schaumburg, Illinois. The $5,248.00 firm fixed-price delivery order is for 4,568,699,941 vials of Cefepime HCl 2 gram, a critical antibiotic medication. The contract has an ultimate completion date of July 8, 2025. Sagent Pharmaceuticals is an established supplier of injectable pharmaceutical products to federal...
- Sagent Pharmaceuticals, Inc. has been awarded a $576 delivery order against the Defense Logistics Agency Troop Support Medical's prime vendor pharmaceutical contract to supply 4561654155 CEFEPIME 2 GRAM SOLUTION FOR INJECTIONS. Performance will take place in Hoffman Estates, Illinois through August 3, 2023. The firm fixed price order was awarded on July 31, 2023 without a set-aside designation. Sagent Pharmaceuticals will deliver the requested cephalosporin antibiotic to support the Defense...
- This is a $17,856 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer, for the supply of 4,568,699,942 vials of the antibiotic cefepime hydrochloride. The award has a completion date of July 8, 2025 and does not utilize any set-aside designations. Sagent Pharmaceuticals holds a $29.6 million single-award indefinite delivery/indefinite quantity (ID/IQ) contract with DLA Troop...
- This is a federal contract award to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,768,863 units of the injectable antibiotic cefepime, in 2 gram dosage. The award is a Firm Fixed Price Delivery Order with a ceiling value of $2,752.00 and an ultimate completion date of September 16, 2024. This contract is not set aside for any special business categories. Sagent...
- This federal contract award worth $22,080.00 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty and generic pharmaceutical manufacturer. The contract is for the delivery of 4,565,768,862 units of the injectable antibiotic Cefepime, 2 grams, to support military healthcare programs and other federal medical needs. This is a firm fixed-price, delivery order contract with a period of performance through September 16, 2024. Sagent...
- This is a federal contract award to Sagent Pharmaceuticals, Inc. to supply the injectable antibiotic cefepime 2 gram solution for injections to the U.S. federal government. The contract, valued at $1,600.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024 and has a period of performance through September 16, 2024. Sagent Pharmaceuticals is a specialty pharmaceutical manufacturer that has been providing a variety of critical care medications,...
- SPE2D021D0003Indefinite Delivery Contract
- SPE2D021D0003-SPE2D325F199FDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded Sagent Pharmaceuticals, Inc. a $4,800 firm fixed-price delivery order on July 8, 2025, for the supply of Cefepime HCL 2 Gram Vials. The contract, which carries an ultimate completion date of July 11, 2025, represents a delivery order against one of Sagent's existing indefinite delivery/indefinite quantity contract vehicles and involves no set-aside designation. Performance will be conducted at Sagent's manufacturing facility in Schaumburg, Illinois. Cefepime is a fourth-generation cephalosporin antibiotic commonly used in military and federal healthcare settings for the treatment of serious bacterial infections. Sagent Pharmaceuticals is a specialty pharmaceutical manufacturer with significant experience supplying injectable medications to federal defense and civilian healthcare programs. The company maintains two major contract vehicles with federal agencies: a $5.5 million Federal Supply Schedule contract with the Department of Veterans Affairs valid through April 2029, and a $29.6 million indefinite delivery/indefinite quantity contract with DLA Troop Support Medical extending through March 2031. These standing agreements enable rapid procurement of essential pharmaceutical products to military treatment facilities and other federal healthcare institutions, with this particular delivery order representing routine fulfillment of ongoing medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 7/8/25 |